INM vs GILD: Which Stock is Better?
Side-by-side comparison of Inmed Pharmaceuticals Inc and Gilead Sciences Inc in 2026
INM
Inmed Pharmaceuticals Inc
$0.70
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | INM | GILD | Winner |
|---|---|---|---|
| Market Cap | $2.36M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.3% | 0.0% | GILD |
| Gross Margin | 29.7% | 78.8% | GILD |
Analyze INM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INM or GILD a better investment?
Comparing INM and GILD: Inmed Pharmaceuticals Inc has a market cap of $2.36M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INM and GILD?
INM (Inmed Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INM or GILD?
GILD has higher revenue growth at 0.0% vs -0.3% for INM.
Which company is more profitable: INM or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 29.7% for INM.
Which is the larger company: INM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $2.36M for INM.
Should I buy INM or GILD in 2026?
Both INM and GILD have investment merit. INM trades at $0.70 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INM and GILD stock?
Key differences: Market Cap ($2.36M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (29.7% vs 78.8%).